← Scroll for more →
Kailera Therapeutics, Inc. (KLRA)
Pharmaceutical Preparations
Latest Price
$12.86
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
8.63
P/B Ratio
1.49
Institutional Ownership
89.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Bain Capital Investors LLC | 26.26M | $578.0M | 20.26% | -- | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 22.58M | $497.0M | 17.42% | -- | 2026-06-30 |
| Rtw Investments, LP | 10.78M | $237.0M | 8.31% | -- | 2026-06-30 |
| Canada Pension Plan Investment Board | 7.30M | $160.0M | 5.64% | -- | 2026-06-30 |
| Atlas Venture Life Science Advisors, LLC | 5.17M | $113.0M | 3.99% | -- | 2026-06-30 |
| FMR LLC | 3.97M | $87.0M | 3.06% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.93M | $86.0M | 3.03% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 3.53M | $77.0M | 2.73% | -- | 2026-06-30 |
| Citadel Advisors LLC | 3.24M | $71.0M | 2.50% | -- | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 3.21M | $70.0M | 2.48% | -- | 2026-06-30 |